Related Experiment Videos
More about: irinotecan-related cholinergic syndrome induced by coadministration of oxaliplatin
Journal of the National Cancer Institute
|January 16, 1999
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Intensified Induction and Post-Remission Therapy for Acute Myeloid Leukaemia.
Hematology (Amsterdam, Netherlands)·2016
Phase II study of acivicin in patients with recurrent high grade astrocytoma.
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia·2008
Imatinib disposition and ABCB1 (MDR1, P-glycoprotein) genotype.
Clinical pharmacology and therapeutics·2007
Wash-in methodology and modeling to determine hepatocellular D-glucose transport in the perfused rat liver.
The Japanese journal of physiology·2005
Docetaxel and carboplatin is an active regimen in advanced non-small-cell lung cancer: a phase II study in Caucasian and Asian patients.
Annals of oncology : official journal of the European Society for Medical Oncology·2003
21-Gene recurrence score assay in pN2-3 Early-Stage breast cancer: a national cancer database study.
Journal of the National Cancer Institute·2026
Projected impact of population-level multi-cancer early detection screening: a discrete event simulation analysis.
Journal of the National Cancer Institute·2026
Late effects after novel therapies for childhood cancer: Anticipating the future landscape of health outcomes for survivors.
Journal of the National Cancer Institute·2026
Hysterectomy-corrected incidence of cervical cancer among women with HIV in the United States, 2001-2019.
Journal of the National Cancer Institute·2026
Markers of cervical intraepithelial neoplasia grade 2 regression and subsequent risk of CIN3.
Journal of the National Cancer Institute·2026
An artificial intelligence algorithm characterizes the deterioration of body composition from systemic therapy for patients with advanced prostate cancer.
Journal of the National Cancer Institute·2026